Comparison of antibody immune responses between BNT162b2 and mRNA-1273 SARS-CoV-2 vaccines in naïve and previously infected individuals.

Duaa W Al-SadeqFarah M ShurrabAhmed IsmailFathima Humaira AmanullahSwapna ThomasNader AldewikHadi M YassineHanan F Abdul RahimLaith Jamal Abu-RaddadGheyath K Nasrallah

Published in: Journal of travel medicine (2021)

Our results showed that the PI vaccinated group produces a higher level of antibodies than the naïve vaccinated group, particularly for those vaccinated with BNT162b2.

Keyphrases

sars cov
immune response
respiratory syndrome coronavirus
toll like receptor
dendritic cells
binding protein
inflammatory response